- F.D.A. Approves Alzheimer’s Drug Despite Fierce Debate Over Whether It Works The New York Times
- FDA approves Biogen Alzheimer’s treatment CNBC Television
- FDA Gives Green Light to Biogen’s Alzheimer’s Drug Bloomberg Markets and Finance
- Approving Biogen’s Alzheimer’s Drug Aducanumab (Aduhelm) Is Big Mistake Bloomberg
- 6 Million Americans Are Rooting for Monday’s Big Stock Market Winner Motley Fool
- View Full Coverage on Google News